M. Lombard

发表

Field use of a vaccinia-rabies recombinant vaccine for the control of sylvatic rabies in Europe and North America.

M. Aubert, B. Brochier, B. Languet, 1996, Revue scientifique et technique.

Further studies on the efficacy of an inactivated African horse sickness serotype 4 vaccine.

C. Mebus, C. House, P. Dubourget, 1994, Vaccine.

Antigen and vaccine banks: technical requirements and the role of the european antigen bank in emergency foot and mouth disease vaccination.

M. Lombard, A. Füssel, 2007, Revue scientifique et technique.

A brief history of vaccines and vaccination.

P. Pastoret, A. Moulin, P P Pastoret, 2007, Revue scientifique et technique.

Mass vaccination campaign against rabies: are dogs correctly protected? The Peruvian experience.

B. Chomel, G. Chappuis, M. Lombard, 1988, Reviews of infectious diseases.

The foot and mouth disease situation in Iran in 1980-84.

M. Amighi, H. Favre, M. Lombard, 1985, Revue scientifique et technique.

Eradication of rabies, using a rec-DNA vaccine.

G. Chappuis, P. Desmettre, M. Lombard, 1996, Journal of biotechnology.

Protective immunity in cattle vaccinated with a commercial scale, inactivated, bivalent vesicular stomatitis vaccine.

J. House, C. House, P. Dubourget, 2003, Vaccine.

OIE/FAO International Scientific Conference on Avian Influenza : Paris, France, 7-8 April, 2005

A. Schudel, M. Lombard, 2006 .